Noor Ul Ain Rehman
Tue, March 31, 2026 astatine 10:06 AM CDT 2 min read
Liquidia Corporation (NASDAQ:LQDA) besides received a standing update from Oppenheimer connected March 12. The steadfast lifted the terms people connected the banal to $19 from $16, reiterating an Underperform standing connected the shares and giving recognition to the company’s squad for executing a beardown aboriginal motorboat of YUTREPIA successful pulmonary arterial hypertension/pulmonary hypertension associated with interstitial lung disease. It posted nett merchandise income of $148.3 cardinal successful fiscal twelvemonth 2025 contempt what it continues to perceive from physicians connected YUTREPIA not being meaningfully differentiated. Oppenheimer believes that the contiguous occurrence speaks much to the increasing request successful PAH/PH-ILD, which the steadfast underestimated.
Liquidia Corporation (NASDAQ:LQDA) is simply a holding institution progressive in, done its subsidiary, processing and commercializing biopharmaceutical products and caller merchandise improvement utilized successful PRINT technology.
While we admit the imaginable of LQDA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Follow Insider Monkey connected Google News.

2 days ago
3



.png)

English (CA) ·
English (US) ·
Spanish (MX) ·